Giacomo Ruotolo

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 3

Top Topics

Cardiovascular Risk Factors

Pseudomonas Aeruginosa

Insulin Resistance

Top Venues

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Kieren J Mather, Tamer Coskun, Edward John Pratt, Zvonko Milicevic, Govinda Weerakkody, Melissa K Thomas, Axel Haupt, Giacomo Ruotolo
Improvements in post-challenge lipid response following tirzepatide treatment in patients with type 2 diabetes. Diabetes, obesity & metabolism (2023)
Jonathan M Wilson, Yanzhu Lin, M Jane Luo, Gary Considine, Amy L Cox, Lenden M Bowsman, Deborah A Robins, Axel Haupt, Kevin L Duffin, Giacomo Ruotolo
The dual glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 receptor agonist tirzepatide improves cardiovascular risk biomarkers in patients with type 2 diabetes: A post hoc analysis. Diabetes, obesity & metabolism 24 (1) (2021)
Jonathan M Wilson, Amir Nikooienejad, Deborah A Robins, William C Roell, Jeffrey S Riesmeyer, Axel Haupt, Kevin L Duffin, Marja-Riitta Taskinen, Giacomo Ruotolo
The dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist, tirzepatide, improves lipoprotein biomarkers associated with insulin resistance and cardiovascular risk in patients with type 2 diabetes. Diabetes, obesity & metabolism 22 (12) (2020)